Trastuzumab combined chemotherapy for the treatment of HER2-positive advanced gastric cancer: A systematic review and meta-analysis of randomized controlled trial

This systematic review and meta-analysis aimed to assess the efficacy of trastuzumab combined with chemotherapy for the treatment in HER2-positive advanced gastric cancer (HER2-PAGC). METHODS: This systematic review and meta-analysis was designed using randomized controlled trials that compared tras...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Chuan, Xu, Yong-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410626/
https://www.ncbi.nlm.nih.gov/pubmed/36042610
http://dx.doi.org/10.1097/MD.0000000000029992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410626/
https://www.ncbi.nlm.nih.gov/pubmed/36042610
http://dx.doi.org/10.1097/MD.0000000000029992

Ejemplares similares